Healthcare & Medical Devices Global On demand · 24-48h

Global Patient Positioning Equipment Market Strategic Research Report

Global Patient Positioning Equipment Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Patient Positioning Equipment Market
$1.06B2025
9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Immobilisation Reproducibility, Pressure Management, Patient Transfer, Others

By Application: Operating Room, Diagnostic Imaging, Radiation Oncology, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Stryker, STERIS, Elekta, Varian, Brainlab, Vision RT, Alcare, Mizuho OSI, C-RAD, Orfit Industries, Sun Nuclear, Xodus Medical, Bionix, Leo Cancer Care, IZI Medical Products, SchureMed, CDR Systems, David Scott, CQ Medical, Candor Denmark, LAP, Guangdong Meicen Medical, Klarity Medical, Shenzhen Tengfeiyu Technology, RAYER Medical Technology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 142 pages
Market size 2025
$1.06B
Billion USD
Forecast CAGR
9%
2025-2032
Forecast 2032
$1.9B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Patient Positioning Equipment market size is predicted to grow from US$ 1,065 million in 2025 to US$ 1,930 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.

Patient Positioning Equipment can be described as the set of devices and accessories used to place and stabilise patients in defined postures so that diagnostic imaging, radiotherapy or surgical procedures can be carried out safely, accurately and comfortably. This category covers products such as radiolucent cushions and sponges, wedges, bolsters, straps, sandbags, vacuum cushions, thermoplastic masks, support boards, gel pads, table pads and specialised positioning systems indexed to treatment or imaging couches. In practice these devices serve two critical roles at once, they help clinicians align the anatomy of interest with beams or imaging fields according to a planned geometry, and they support the patient physically so that the required position can be maintained with minimal movement and acceptable comfort during the entire procedure.

The patient positioning equipment market is becoming a more strategic component of modern care pathways rather than a set of simple accessories. As radiotherapy, image guided interventions and minimally invasive surgery demand higher geometric accuracy and reproducibility, providers are investing in positioning systems that combine mechanical stability, ergonomic design and workflow efficiency across the full course of treatment or diagnosis. Vendors are moving beyond commodity pads and supports toward integrated solutions that interface with imaging and treatment tables, support advanced techniques in oncology and interventional radiology, and help reduce complications such as pressure injuries or set up errors. At the same time, hospital purchasing decisions are increasingly influenced by evidence of clinical benefit, compatibility with existing imaging and treatment platforms, and the ability of manufacturers to provide training, digital documentation and long term service support, which favours specialised positioning companies and diversified medtech groups with strong clinical relationships.

This report presents a comprehensive overview of the global Patient Positioning Equipment market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Immobilisation Reproducibility
  • Pressure Management
  • Patient Transfer
  • Others

Segment by Target Body Region

  • Head Immobilization System
  • Body Immobilization System
  • Limb Immobilization System
  • Whole-Body/Integrated Immobilization System

Segment by Intelligence

  • Basic Type
  • Advanced Type

Segment by players, this report covers

  • Stryker
  • STERIS
  • Elekta
  • Varian
  • Brainlab
  • Vision RT
  • Alcare
  • Mizuho OSI
  • C-RAD
  • Orfit Industries
  • Sun Nuclear
  • Xodus Medical
  • Bionix
  • Leo Cancer Care
  • IZI Medical Products
  • SchureMed
  • CDR Systems
  • David Scott
  • CQ Medical
  • Candor Denmark
  • LAP
  • Guangdong Meicen Medical
  • Klarity Medical
  • Shenzhen Tengfeiyu Technology
  • RAYER Medical Technology

Segment by Application

  • Operating Room
  • Diagnostic Imaging
  • Radiation Oncology
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Patient Positioning Equipment market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Operating Room, Diagnostic Imaging, Radiation Oncology evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Patient Positioning Equipment Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.06B
2025
Forecast
$1.9B
2032
CAGR
9%
2025–2032
Regions
5
global
Key companies
StrykerSTERISElektaVarianBrainlabVision RTAlcareMizuho OSI
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Immobilisation ReproducibilityPressure ManagementPatient TransferOthers
By Application
Operating RoomDiagnostic ImagingRadiation OncologyOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Immobilisation Reproducibility
  • 3.1.3 Pressure Management
  • 3.1.4 Patient Transfer
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Operating Room
  • 4.1.3 Diagnostic Imaging
  • 4.1.4 Radiation Oncology
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Stryker
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 STERIS
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Elekta
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Varian
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Brainlab
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Vision RT
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Alcare
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Mizuho OSI
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 C-RAD
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Orfit Industries
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Sun Nuclear
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Xodus Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Bionix
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Leo Cancer Care
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 IZI Medical Products
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 SchureMed
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 CDR Systems
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 David Scott
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 CQ Medical
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Candor Denmark
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 LAP
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Guangdong Meicen Medical
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Klarity Medical
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Shenzhen Tengfeiyu Technology
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 RAYER Medical Technology
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Patient Positioning Equipment market?
The global Patient Positioning Equipment market is estimated at US$ 1.06 billion in 2025 (base year) and is projected to reach US$ 1.93 billion by 2032.
What is the forecast CAGR for the Patient Positioning Equipment market?
The market is expected to grow at a CAGR of 9.0% from 2026 to 2032, expanding from US$ 1.06 billion in 2025 to US$ 1.93 billion in 2032, roughly 1.8 times its base-year value.
What is Patient Positioning Equipment?
Patient Positioning Equipment can be described as the set of devices and accessories used to place and stabilise patients in defined postures so that diagnostic imaging, radiotherapy or surgical procedures can be carried out safely, accurately and comfortably. This category covers products such as radiolucent cushions and sponges, wedges, bolsters, straps, sandbags, vacuum cushions, thermoplastic masks, support boards, gel pads, table pads and specialised positioning systems indexed to treatment or imaging couches.
How is the Patient Positioning Equipment market segmented by type?
By type, the market is segmented into Immobilisation Reproducibility, Pressure Management, Patient Transfer and Others.
What are the key applications of Patient Positioning Equipment?
Key applications covered include Operating Room, Diagnostic Imaging, Radiation Oncology and Others.
Which companies are profiled in the Patient Positioning Equipment market report?
Key players profiled include Stryker, STERIS, Elekta, Varian, Brainlab, Vision RT, Alcare and Mizuho OSI, among 25 companies covered in total.
What geographies does the Patient Positioning Equipment market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Patient Positioning Equipment market report?
The report is intended for manufacturers and solution providers, distributors and end users in Operating Room, Diagnostic Imaging and Radiation Oncology, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Patient Positioning Equipment market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.